Aspercreme with Lidocaine Pain Relieving Creme
- Product NDC
- 41167-0582
- 11-digit product format
- 411670582
- Labeler code
- 41167
- Product ID
- 41167-0582_6785c38d-594d-434d-b6f7-41b6190c8ba6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lidocaine Hydrochloride
- Dosage form
- LOTION
- Route
- TOPICAL
- Labeler
- Chattem, Inc.
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-12-01
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 4 g/100g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41167-0582 | 41167-0582-2 | D | Discontinued by firm | 2026-11-16 | |
| excluded package | package | 41167-0582 | 41167-0582-4 | D | Discontinued by firm | 2026-11-16 | |
| excluded package | package | 41167-0582 | 41167-0582-5 | D | Discontinued by firm | 2026-11-16 | |
| excluded package | package | 41167-0582 | 41167-0582-8 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0582-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0582-8 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0582-5 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0582-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0582-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0582-8 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0582-5 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0582-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0582-4 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0582-8 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0582-5 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0582-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0582-4 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0582-8 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0582-5 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0582-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0582-4 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0582-8 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0582-5 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0582-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0582-4 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0582-8 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0582-5 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0582-2 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41167-0582-8 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41167-0582-5 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41167-0582-4 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41167-0582-8 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41167-0582-5 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41167-0582-4 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41167-0582-8 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41167-0582-5 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41167-0582-4 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41167-0582-4 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41167-0582-5 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41167-0582-8 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41167-0582-8 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41167-0582-4 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41167-0582-8 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41167-0582-4 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspercreme with Lidocaine Pain Relieving Creme
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 4 g/100g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-0582-1 | Aspercreme with Lidocaine Pain Relieving Creme | 121 g in 1 BOTTLE | LOTION | 121 | 14 | |
| 41167-0582-1 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-2 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-2 | Aspercreme with Lidocaine Pain Relieving Creme | 49.6 g in 1 TUBE | LOTION | 49.6 | 14 | |
| 41167-0582-4 | Aspercreme with Lidocaine Pain Relieving Creme | 113 g in 1 BOTTLE | LOTION | 113 | 14 | |
| 41167-0582-4 | Aspercreme with Lidocaine Pain Relieving Creme | 2 in 1 CARTON | LOTION | 2 | 14 | |
| 41167-0582-5 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-5 | Aspercreme with Lidocaine Pain Relieving Creme | 76.5 g in 1 BOTTLE | LOTION | 76.5 | 14 | |
| 41167-0582-8 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-8 | Aspercreme with Lidocaine Pain Relieving Creme | 133 g in 1 BOTTLE | LOTION | 133 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-0582-2 | GM - Gram | 41167-0582 | e21f60c8-faf1-4247-a807-ffe2d95ec4e9 | 1 | 2021-08-05 |
| 41167-0582-5 | GM - Gram | 41167-0582 | d7371561-be61-41ab-a79d-fb9e4a80e592 | 1 | 2020-04-20 |
| 41167-0582-8 | GM - Gram | 41167-0582 | 3c72626a-9fd8-49ef-872a-d9c37ab432c3 | 1 | 2020-09-14 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41167-0582 | ASPERCREME WITH LIDOCAINE PAIN RELIEVING CREME (LIDOCAINE HYDROCHLORIDE) LOTION [CHATTEM, INC.] | 14 | Current NDC, Legacy NDC, 10 package rows | 20250302_d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Therapy | MENTHOL | AHC VENTURES CORP DBA CRYODERM | 52fff03e-eba2-4604-a71c-2522468f627b | 2025-09-02 | Warnings | M017 |
| Pain Relieving Cold Therapy | MENTHOL | AHC VENTURES CORP DBA CRYODERM | de210c3a-c24e-cefd-e053-2a95a90a93ff | 2025-09-02 | Warnings | M017 |
| Pain Relieving Roll-On | MENTHOL, CAMPHOR, CAPSAICIN | AHC VENTURES CORP DBA CRY | 799751f3-726a-42de-934e-dbc3cd1cb8b8 | 2025-09-02 | Warnings | M017 |
| Pain Relieving Cold Therapy | MENTHOL | AHC VENTURES CORP DBA CRYODERM | de0c9a73-dbc0-599e-e053-2a95a90a7986 | 2025-09-02 | Warnings | M017 |
| Cold Therapy | MENTHOL | AHC VENTURES CORP DBA CRYODERM | 90334420-5f81-4284-9a57-42e134ce362f | 2025-09-02 | Warnings | M017 |
| KNEE PAIN RELIRF Patch | CAMPHOR, MENTHOL | Shenzhen Finona Information Technology Co., Ltd | 3db971ef-d7fa-0171-e063-6294a90aa58b | 2025-09-01 | Warnings | M017 |
| Bikini Zone Medicated Creme | LIDOCAINE | Kingsway Pharmaceuticals dba NFI, LLC | 300ac57e-844a-4840-b285-41ff5518e6b6 | 2025-08-29 | Warnings | M017 |
| Bikini Zone Medicated Gel | LIDOCAINE | Kingsway Pharmaceuticals dba NFI, LLC | 30b85890-e72d-4af7-bda9-e7744abc92af | 2025-08-29 | Warnings | M017 |
| Sumifun Lidocaine Pain Relief Gel-Patch | LIDOCAINE | Guangzhou Zhupuyou E-commerce Co., Ltd | 3d7dc8cc-0680-d94d-e063-6394a90ac8e8 | 2025-08-29 | Warnings | M017 |
| TKTALKER NUMBING | NUMBING | Shenzhen Shandian Jingling Technology Co., Ltd. | 3d7e6757-f183-2a68-e063-6294a90ae4ca | 2025-08-29 | Warnings | M017 |
| PBZ OTC | TRIPELENNAMINE HCL 1% | Kingsway Pharmaceuticals dba NFI, LLC | 12f72d74-018f-4bc6-acd4-175ca3af4c6d | 2025-08-29 | Warnings | M017 |
| else. | LIDOCAINE | Else Co. | 3d6c7b10-ed03-bbde-e063-6294a90ae92f | 2025-08-28 | Warnings | M017 |
| Mountain Ice Pain Relief | MENTHOL | Mountainside Medical Equipment, Inc. | c79fdd91-16f4-4ae0-bee4-d37c05ed2074 | 2025-08-28 | Warnings | M017 |
| HealthWise 4% Lidocaine Cream 2.7 oz | LIDOCAINE HYDROCHLORIDE | Veridian Healthcare | f39eb3d0-e153-4f50-85b1-ad5c677d176c | 2025-08-28 | Warnings | M017 |
| HealthWise Overnight Menthol Patch | MENTHOL | Veridian Healthcare | 6379f50d-2878-46ca-8acb-71c4554585e9 | 2025-08-28 | Warnings | M017 |
| Anti Itch Maximum Relief | PRAMOXINE HYDROCHLORIDE AND MENTHOL | Natureplex LLC | 75de3d5e-ecbe-4d04-a39d-792200e6ee32 | 2025-08-28 | Warnings | M017 |
| NicDuic Quit Smoking Nicotine Patches | NICOTINE TRANSDERMAL PATCHES | Shenzhen Paxi Trading Co., Ltd. | 3d5718f3-c175-6b64-e063-6394a90aa6f1 | 2025-08-27 | Warnings | M017 |
| ARCTIC HEAT | MENTHOL, METHYL SALICYLATE | Renu Laboratories, LLC | 402df5c1-b8cb-17a2-e054-00144ff8d46c | 2025-08-27 | Warnings | M017 |
| PROHEAL HYDROCORTISONE 1% MAXIMUM STRENGTH PLUS ALOE | HYDROCORTISONE | Click Industries LLC | 328c389c-7e05-4892-a9b3-b6a753f4935a | 2025-08-25 | Warnings | M017 |
| Yeheal | CAMPHOR, MENTHOL, ISOPROPYL ALCOHOL | Shenzhen Yeheal Biotechnology Co., Ltd | 3cf1bc74-3060-6d63-e063-6294a90a9f5c | 2025-08-22 | Warnings | M017 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41167-0582-1 | 41167058201 | 1 BOTTLE in 1 CARTON (41167-0582-1) / 121 g in 1 BOTTLE | 1 bottle | 2020-11-01 | 0000-00-00 | No | No | Current |
| 41167-0582-2 | 41167058202 | 1 TUBE in 1 CARTON (41167-0582-2) > 49.6 g in 1 TUBE | 1 tube | 2014-12-01 | 0000-00-00 | No | No | Current |
| 41167-0582-4 | 41167058204 | 2 BOTTLE in 1 CARTON (41167-0582-4) > 113 g in 1 BOTTLE | 2 bottle | 2014-12-01 | 0000-00-00 | No | No | Current |
| 41167-0582-5 | 41167058205 | 1 BOTTLE in 1 CARTON (41167-0582-5) > 76.5 g in 1 BOTTLE | 1 bottle | 2014-12-01 | 0000-00-00 | No | No | Current |
| 41167-0582-8 | 41167058208 | 1 BOTTLE in 1 CARTON (41167-0582-8) > 133 g in 1 BOTTLE | 1 bottle | 2014-12-01 | 0000-00-00 | No | No | Current |